SCbio, in partnership with The Massachusetts Biotechnology Council, has opened the applications for its new accelerator program, SCbioDrive.
A biannual program, SCbioDrive will select up to six seed-stage life sciences companies for an eight-week hybrid program designed to advance their platforms and technologies through expert business curricula, industry guidance and mentorship all at no cost, according to a news release.
Emerging therapeutics companies are invited to apply for the inaugural Fall 2024 program by June 28.
Startups selected through a rigorous two-step vetting process will:
- Participate in six business-focused curriculum modules taught by seasoned experts from Charles River Labs, Deloitte, Maynard Nexsen, Medpoint, and more;
- Partner with a small, dedicated group of industry mentors;
- Connect with SCbio’s global life sciences network through ecosystem-wide events and targeted 1:1 partnering opportunities; and
- Experience an End-of-program Demo Day in Charleston, where they will present their company to a curated group of potential investors and industry leaders.
“The resources and knowledge that the SCbioDrive inaugural cohort will gain from the expert companies leading this curriculum will be invaluable,” said SCbio President and CEO James Chappell in the release. “We want this program to show entrepreneurs that South Carolina is the state where businesses, at their earliest stages, are set up for success and sustained growth.”
Related: University of South Carolina unveils statewide neurology health network expansion
Related: Why South Carolina’s health care industry faces a ‘watershed moment’
The Fall 2024 accelerator will run from Sept. 23 to Nov. 21. Applications for the inaugural program cohort are available by clicking here .
“Our vision for Drive has always been to support diverse founders with exciting science no matter where they are starting their company,” said MassBio President and CEO Kendalle Burlin O’Connell in the release. “We’re pleased to see SCbio take the MassBioDrive model and put a Palmetto State spin on it to accelerate their homegrown startups toward success.”
SCbio is South Carolina’s investor-driven economic development organization focused on building, advancing and growing the life sciences industry in the state, according to the release. It represents more than 1,000 organizations employing more than 87,000 professionals across the state and supports and advances organizations in multiple arenas including pharmaceuticals, medical devices and equipment, digital health, research and medical labs, bioscience distribution, bio-ag and more.
Copyright © 2024 BridgeTower Media. All Rights Reserved.
Most Popular
Comments / 0